CRC Appoints Jason Casarella, MBA as Chief Commercial Officer Breaking News

CRC Appoints Jason Casarella, MBA as Chief Commercial Officer

ST. PETERSBURG, Fla., Sept. 2, 2025 /PRNewswire/ -- Cognitive Research Corporation (CRC), a leading full-service…

cogres1September 2, 2025

The Renaissance of Psychedelic Research: History, Protocols, and Forward Trajectories Expert Insights

The Renaissance of Psychedelic Research: History, Protocols, and Forward Trajectories

Psychedelic medicine has re-emerged as one of the most exciting frontiers in psychiatric and psychological…

cogres1August 20, 2025

CRC Becomes Accredited Medidata Rave® EDC Partner Breaking News

CRC Becomes Accredited Medidata Rave® EDC Partner

ST. PETERSBURG, Fla., Aug. 12, 2025 /PRNewswire/ -- Cognitive Research Corporation (CRC), a full-service CRO…

cogres1August 12, 2025

Mastering Agitation Endpoints with Assessment Expertise Collaboration Success Stories

Mastering Agitation Endpoints with Assessment Expertise

Consistent, high-quality assessments are essential in agitation trials. In this focused case study, see how…

cogres1July 30, 2025

Seamless Execution Across Early-Phase Alzheimer’s Trials Collaboration Success Stories

Seamless Execution Across Early-Phase Alzheimer’s Trials

In the face of pandemic-era recruitment barriers and aggressive timelines, CRC partnered with a sponsor…

cogres1July 15, 2025

The Expanding Role of GLP-1 Receptor Agonists in CNS Clinical Research Expert Insights

The Expanding Role of GLP-1 Receptor Agonists in CNS Clinical Research

(GLP-1 RAs), initially developed for the treatment of type 2 diabetes, have rapidly become a…

cogres1July 1, 2025

4 Ways Strategic Site Selection Maximizes the Value Equation Expert Insights

4 Ways Strategic Site Selection Maximizes the Value Equation

In clinical trials, success hinges not just on protocol design and quality data but on…

cogres1April 10, 2025

Expedited Completion of a Complex Driving Study Collaboration Success Stories

Expedited Completion of a Complex Driving Study

Driving In the Fast Lane Discover how CRC leveraged our proprietary driving simulator to swiftly…

cogres1March 26, 2025

Next-Day Effects: Are Medications Leaving Drivers at Risk? Expert Insights

Next-Day Effects: Are Medications Leaving Drivers at Risk?

COMPLIANCE WITH 2017 FDA GUIDANCE FOR EVALUATING DRUG-IMPAIRED DRIVING Prescription and over-the-counter drugs can save…

cogres1December 18, 2024

World Mental Health Day 2024 Inside CRC

World Mental Health Day 2024

Celebrating Progress in Mental Health Care On World Mental Health Day, we reflect on the…

cogres1October 10, 2024

Two FDA Approvals to Advance Migraine Care Collaboration Success Stories

Two FDA Approvals to Advance Migraine Care

Proactive Mitigation to Support Program Success Learn how CRC’s proactive approach and real-time data oversight…

cogres1October 1, 2024

CRC Expands Medical Leadership Team with Appointment of Accomplished Medical Directors Breaking News

CRC Expands Medical Leadership Team with Appointment of Accomplished Medical Directors

Cognitive Research Corporation (CRC), a leading CNS-focused clinical research organization, proudly announces the addition of…

cogres1September 24, 2024